Northwest Biotherapeutics raised $5M through a convertible note financing led by Yorkville Advisors for general corporate purposes.
Amount Raised
$5 Million
Round Type
Convertible Note
BethesdaBiotechnologyHealthcareresearchInvestors
Description
Northwest Biotherapeutics announced a $5 million convertible Promissory Note financing with Yorkville Advisors. The company plans to use the proceeds for general corporate purposes, including its lead product and in-licensed portfolios.
Quick answer
Northwest Biotherapeutics raised $5 Million in a Convertible Note round, dated December 31, 2024. Investors: Ya II Pn, Ltd. and Yorkville Advisors Global, LP. Northwest Biotherapeutics is based in Bethesda, Maryland, United States.
- How much did Northwest Biotherapeutics raise?
- Northwest Biotherapeutics raised $5 Million in a Convertible Note round on December 31, 2024.
- Who invested in Northwest Biotherapeutics?
- Ya II Pn, Ltd. and Yorkville Advisors Global, LP are named as investors in this round.
- What does Northwest Biotherapeutics do?
- Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind..
- Where is Northwest Biotherapeutics based and how big is it?
- Northwest Biotherapeutics is based in Bethesda, Maryland, United States. Fundz records about 25 employees.
- Who are the decision-makers at Northwest Biotherapeutics?
- Fundz holds 5 contacts at Northwest Biotherapeutics, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and research around the same time
Companies in the same sectors as Northwest Biotherapeutics that raised within 45 days of this round, from Fundz verified event records.
- Hummingbird Healthcare raised $19M on February 14, 2025.
- IBI Ag raised $6.1M (Series A) on February 13, 2025.
- Microbot Medical raised $13M on February 11, 2025.
- Pneuma Respiratory raised $3.3M (Seed) on February 10, 2025.
- ChromaCode raised $3.8M (Seed) on January 30, 2025.
- Axial Therapeutics raised $19M on January 28, 2025.
Who to call at Northwest Biotherapeutics, and when
A new round usually means Northwest Biotherapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Northwest Biotherapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Northwest Biotherapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Northwest Biotherapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Northwest Biotherapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Northwest Biotherapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.